Phenotypic characterization of drug resistance and tumor initiating cancer stem cells from human bone tumor osteosarcoma cell line OS-77

被引:1
|
作者
Zhang, Yue [1 ]
Quan, Ren-Fu [2 ]
Chen, Wei-Shan [1 ]
Ye, Zhao-Ming [1 ]
Li, Wei-Xu [1 ]
Yang, Di-Sheng [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Dept Orthopaed, Hangzhou 310052, Zhejiang, Peoples R China
[2] Zhejiang Univ, Xiaoshan Tradit Chinese Med Hosp, Dept Orthopaed, Hangzhou 311201, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Anticancer drug; Cancer stem cell; Drug resistance; Metastasis; IDENTIFICATION; OCT4;
D O I
10.3329/bjp.v9i3.19891
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cancer stem cell theory suggest that presence of small subpopulation of cancer stem cells are the major implication in the cancer treatment and also responsible for tumor recurrence. Based on Hoechst 33342 dye exclusion technique, we have identified about 3.3% of cancer stem like side population (SP) cells from human osteosarcoma OS-77 cell line whose prevalence is significantly reduced to 0.3% after treatment with verapamil. The sphere formation assay revealed that osteosarcoma SP cells are highly capable to form tumor spheres (sarcospheres). Further by immunocytochemistry and RT-PCR, we show that OS-77 SP cells have enhanced expression of stem cell surface markers such as CD44, Nanog and ATP-binding cassette (ABC) transporter gene (ABCG2) which contributes to self-renewal and drug resistance, respectively. Our findings help to designing a novel therapeutic drug which could effectively target the cancer stem cells and prevent the tumor relapse.
引用
收藏
页码:437 / 442
页数:6
相关论文
共 50 条
  • [11] Genetic and molecular characterization of the human Osteosarcoma 3AB-OS cancer stem cell line: A possible model for studying osteosarcoma origin and stemness
    Di Fiore, Riccardo
    Fanale, Daniele
    Drago-Ferrante, Rosa
    Chiaradonna, Ferdinando
    Giuliano, Michela
    De Blasio, Anna
    Amodeo, Valeria
    Corsini, Lidia R.
    Bazan, Viviana
    Tesoriere, Giovanni
    Vento, Renza
    Russo, Antonio
    JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (06) : 1189 - 1201
  • [12] Lung cancer tumorigenicity and drug resistance are enhanced through ALDHhiCD44hi tumor initiating cells
    Liu, Jing
    Xiao, Zhijie
    Wong, Sunny Kit-Man
    Tin, Vicky Pui-Chi
    Ho, Ka-Yan
    Wang, Junwen
    Sham, Mai-Har
    Wong, Maria Pik
    ONCOTARGET, 2013, 4 (10) : 1686 - 1699
  • [13] Comparison of cancer stem cell antigen expression by tumor cell lines and by tumor biopsies from dogs with melanoma and osteosarcoma
    Guth, Amanda M.
    Deogracias, Mike
    Dow, Steven W.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2014, 161 (3-4) : 132 - 140
  • [14] BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation
    Wang, Lin
    Park, Paul
    La Marca, Frank
    Than, Khoi D.
    Lin, Chia-Ying
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (06) : 1013 - 1024
  • [15] Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells Implications for drug resistance and in vitro drug screening models
    Sabisz, Michal
    Skladanowski, Andrzej
    CELL CYCLE, 2009, 8 (19) : 3208 - 3217
  • [16] Tumor Cells Positive and Negative for the Common Cancer Stem Cell Markers Are Capable of Initiating Tumor Growth and Generating Both Progenies
    Huang, Sheng-Dong
    Yuan, Yang
    Tang, Hao
    Liu, Xiao-Hong
    Fu, Chuan-Gang
    Cheng, He-Zhong
    Bi, Jian-Wei
    Yu, Yong-Wei
    Gong, De-Jun
    Zhang, Wei
    Chen, Jie
    Xu, Zhi-Yun
    PLOS ONE, 2013, 8 (01):
  • [17] Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
    George J. Klarmann
    Elaine M. Hurt
    Lesley A. Mathews
    Xiaohu Zhang
    Maria A. Duhagon
    Tashan Mistree
    Suneetha B. Thomas
    William L. Farrar
    Clinical & Experimental Metastasis, 2009, 26 : 433 - 446
  • [18] Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
    Klarmann, George J.
    Hurt, Elaine M.
    Mathews, Lesley A.
    Zhang, Xiaohu
    Duhagon, Maria A.
    Mistree, Tashan
    Thomas, Suneetha B.
    Farrar, William L.
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (05) : 433 - 446
  • [19] Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line
    Fang, Douglas D.
    Cao, Joan
    Jani, Jitesh P.
    Tsaparikos, Konstantinos
    Blasina, Alessandra
    Kornmann, Jill
    Lira, Maruja E.
    Wang, Jianying
    Jirout, Zuzana
    Bingham, Justin
    Zhu, Zhou
    Gu, Yin
    Los, Gerrit
    Hostomsky, Zdenek
    VanArsdale, Todd
    FRONTIERS OF MEDICINE, 2013, 7 (04) : 462 - 476
  • [20] Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus
    Machida, Keigo
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2013, 3 (02) : 152 - 164